Sir Greg Winter
Sir Greg is former Master of Trinity College Cambridge, he is both scientist and entrepreneur. As researcher, Sir Greg humanized antibodies for therapies using phage display, for which he was awarded the Nobel Prize in Chemistry 2018. As entrepreneur, Sir Greg founded and built the companies Cambridge Antibody Technology, Bicycle Therapeutics and Domantis. Sir Greg’s work is behind globally top-selling human antibody drugs with big and pioneering impact on global health.
Trinity in Japan
Chair and Founder: Gerhard Fasol